Summary of Study ST001923
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001214. The data can be accessed directly via it's Project DOI: 10.21228/M8SH7V This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001923 |
Study Title | Urine-Based Metabolomics and Machine Learning Reveals Metabolites Associated with Renal Cell Carcinoma Progression |
Study Summary | Every year, hundreds of thousands of cases of renal carcinoma (RCC) are reported worldwide. Accurate staging of the disease is important for treatment and prognosis purposes; however, contemporary methods such as computerized tomography (CT) and biopsies are expensive and prone to sampling errors, respectively. As such, a non-invasive diagnostic assay for staging would be beneficial. This study aims to investigate urine metabolites as potential biomarkers to stage RCC. In the study, we identified a panel of such urine metabolites with machine learning techniques. |
Institute | University of Georgia |
Department | Department of Biochemistry and Molecular Biology |
Laboratory | Edison Lab |
Last Name | Bifarin |
First Name | Olatomiwa |
Address | 315 Riverbend Rd, Athens, GA 30602 |
olatomiwa.bifarin25@uga.edu | |
Phone | 757-405-4379 |
Submit Date | 2021-08-16 |
Num Groups | Two |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2021-10-18 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001214 |
Project DOI: | doi: 10.21228/M8SH7V |
Project Title: | Urine-Based Metabolomics and Machine Learning Reveals Metabolites Associated with Renal Cell Carcinoma Progression |
Project Type: | multi-platform urine-based metabolomics |
Project Summary: | Every year, hundreds of thousands of cases of renal carcinoma (RCC) are reported worldwide. Accurate staging of the disease is important for treatment and prognosis purposes; however, contemporary methods such as computerized tomography (CT) and biopsies are expensive and prone to sampling errors, respectively. As such, a non-invasive diagnostic assay for staging would be beneficial. This study aims to investigate urine metabolites as potential biomarkers to stage RCC. In the study, we identified a panel of such urine metabolites with machine learning techniques. |
Institute: | University of Georgia |
Department: | Biochemistry and Molecular Biology |
Laboratory: | Fernandez Lab/ Edison Lab |
Last Name: | Bifarin |
First Name: | Olatomiwa |
Address: | 315 Riverbend Rd, Athens, GA 30602 |
Email: | olatomiwa.bifarin25@uga.edu |
Phone: | (706) 542-4401 Lab: 1045 |
Subject:
Subject ID: | SU002001 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Species Group: | Mammals |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Factor |
---|---|---|
SA177936 | C036 | Early |
SA177937 | C037 | Early |
SA177938 | C039 | Early |
SA177939 | C058 | Early |
SA177940 | C102 | Early |
SA177941 | C083 | Early |
SA177942 | C095 | Early |
SA177943 | C061 | Early |
SA177944 | C084 | Early |
SA177945 | C040 | Early |
SA177946 | C057 | Early |
SA177947 | C070 | Early |
SA177948 | C049 | Early |
SA177949 | C001 | Early |
SA177950 | C053 | Early |
SA177951 | C047 | Early |
SA177952 | C046 | Early |
SA177953 | C027 | Early |
SA177954 | C054 | Early |
SA177955 | C096 | Early |
SA177956 | C101 | Early |
SA177957 | C063 | Early |
SA177958 | C009 | Early |
SA177959 | C089 | Early |
SA177960 | C012 | Early |
SA177961 | C013 | Early |
SA177962 | C081 | Early |
SA177963 | C082 | Early |
SA177964 | C088 | Early |
SA177965 | C093 | Early |
SA177966 | C092 | Early |
SA177967 | C087 | Early |
SA177968 | C091 | Early |
SA177969 | C022 | Early |
SA177970 | C024 | Early |
SA177971 | C077 | Early |
SA177972 | C062 | Early |
SA177973 | C020 | Early |
SA177974 | C016 | Early |
SA177975 | C018 | Early |
SA177976 | C085 | Early |
SA177977 | C064 | Late |
SA177978 | C073 | Late |
SA177979 | C072 | Late |
SA177980 | C078 | Late |
SA177981 | C086 | Late |
SA177982 | C099 | Late |
SA177983 | C097 | Late |
SA177984 | C066 | Late |
SA177985 | C050 | Late |
SA177986 | C026 | Late |
SA177987 | C060 | Late |
SA177988 | C030 | Late |
SA177989 | C031 | Late |
SA177990 | C025 | Late |
SA177991 | C021 | Late |
SA177992 | C011 | Late |
SA177993 | C014 | Late |
SA177994 | C015 | Late |
SA177995 | C019 | Late |
SA177996 | C033 | Late |
SA177997 | C028 | Late |
SA177998 | C048 | Late |
SA177999 | C051 | Late |
SA178000 | C059 | Late |
SA178001 | C045 | Late |
SA178002 | C044 | Late |
SA178003 | C043 | Late |
SA178004 | C041 | Late |
SA178005 | C038 | Late |
SA178006 | C005 | Unknown |
SA178007 | C006 | Unknown |
SA178008 | C004 | Unknown |
SA178009 | C007 | Unknown |
SA178010 | C002 | Unknown |
SA178011 | C003 | Unknown |
SA178012 | C079 | Unknown |
SA178013 | C074 | Unknown |
SA178014 | C076 | Unknown |
SA178015 | C034 | Unknown |
SA178016 | C065 | Unknown |
SA178017 | C052 | Unknown |
Showing results 1 to 82 of 82 |
Collection:
Collection ID: | CO001994 |
Collection Summary: | Urine samples were collected at the Emory University Hospital |
Collection Protocol Filename: | 2_Collection_protocol_RCC_AUG2021.docx |
Sample Type: | Urine |
Treatment:
Treatment ID: | TR002013 |
Treatment Summary: | There were no treatment in the study, urine samples of healthy subjects and renal cell carcinoma patients were collected. |
Sample Preparation:
Sampleprep ID: | SP002007 |
Sampleprep Summary: | Urine’s samples were prepared for both NMR and MS experiments |
Sampleprep Protocol Filename: | 3_Sample preparation protocol_RCC_AUG2021.docx |
Processing Storage Conditions: | -80℃ |
Combined analysis:
Analysis ID | AN003125 | AN003126 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | HILIC | HILIC |
Chromatography system | Q Exactive HF | Q Exactive HF |
Column | Waters ACQUITY UPLC BEH HILIC (75 x 2.1mm,1.7um) | Waters ACQUITY UPLC BEH HILIC (75 x 2.1mm,1.7um) |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive HF hybrid Orbitrap | Thermo Q Exactive HF hybrid Orbitrap |
Ion Mode | POSITIVE | NEGATIVE |
Units | AU | AU |
Chromatography:
Chromatography ID: | CH002310 |
Instrument Name: | Q Exactive HF |
Column Name: | Waters ACQUITY UPLC BEH HILIC (75 x 2.1mm,1.7um) |
Chromatography Type: | HILIC |
MS:
MS ID: | MS002906 |
Analysis ID: | AN003125 |
Instrument Name: | Thermo Q Exactive HF hybrid Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | -- |
Ion Mode: | POSITIVE |
MS ID: | MS002907 |
Analysis ID: | AN003126 |
Instrument Name: | Thermo Q Exactive HF hybrid Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | -- |
Ion Mode: | NEGATIVE |